Pyxis Oncology Inc (PYXS)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart

Ticker: PYXS Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale

Past 90 days

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Search

Download results

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Total value	Details
2023-09-28	2023-09-28	B Purchase	Connealy Pamela Ann CFO and COO Officer	8,000 +1.0% 1.87 14,960 USD	8,000 +1.0%	1.87	14,960 USD
2023-09-27	2023-09-27	B Purchase	Connealy Pamela Ann CFO and COO Officer	6,426 +0.8% 1.85 11,868 USD	6,426 +0.8%	1.85	11,868 USD
2023-09-27	2023-09-27	B Purchase	Wadhane Jitendra Chief Accounting Officer Officer	2,500 +1.1% 1.87 4,675 USD	2,500 +1.1%	1.87	4,675 USD
2023-09-25	2023-09-25	B Purchase	Wadhane Jitendra Chief Accounting Officer Officer	5,000 +2.3% 1.77 8,850 USD	5,000 +2.3%	1.77	8,850 USD
2023-09-25	2023-09-25	B Purchase	Connealy Pamela Ann CFO and COO Officer	12,000 +1.5% 1.67 20,044 USD	12,000 +1.5%	1.67	20,044 USD
2023-09-22	2023-09-22	B Purchase	Connealy Pamela Ann CFO and COO Officer	5,000 +0.6% 1.74 8,695 USD	5,000 +0.6%	1.74	8,695 USD
2023-09-22	2023-09-22	B Purchase	Wadhane Jitendra Chief Accounting Officer Officer	2,500 +1.2% 1.74 4,349 USD	2,500 +1.2%	1.74	4,349 USD
2023-09-18	2023-09-18	S Sale	Sullivan Lara President and CEO Executive Director	8,541 -0.4% 2.10 17,936 USD	8,541 -0.4%	2.10	17,936 USD
2023-09-18	2023-09-14	S Sale	Sullivan Lara President and CEO Executive Director	100 -0.0% 2.25 225 USD	100 -0.0%	2.25	225 USD
2023-09-13	2023-09-13	S Sale	Sullivan Lara President and CEO Executive Director	3,000 -0.1% 2.27 6,816 USD	3,000 -0.1%	2.27	6,816 USD
2023-09-13	2023-09-12	S Sale	Sullivan Lara President and CEO Executive Director	4,917 -0.2% 2.25 11,071 USD	4,917 -0.2%	2.25	11,071 USD
2023-09-13	2023-09-11	S Sale	Sullivan Lara President and CEO Executive Director	20,000 -0.8% 2.27 45,414 USD	20,000 -0.8%	2.27	45,414 USD
2023-03-21	2023-03-17	B Purchase	PFIZER INC Major owner	1,811,594 +43.8% 2.76 4,999,999 USD	1,811,594 +43.8%	2.76	4,999,999 USD
2022-04-25	2022-04-21	S Sale	Chin Mark Former Director	1,745,761 -100.0% 3.05 5,324,571 USD	1,745,761 -100.0%	3.05	5,324,571 USD
2021-12-09	2021-12-08	B Purchase	Cline Darren S Non-Executive Director	10,000 +inf% 9.39 93,885 USD	10,000 +inf%	9.39	93,885 USD
2021-11-19	2021-11-18	B Purchase	Civik Thomas Non-Executive Director	15,700 +inf% 12.74 200,018 USD	15,700 +inf%	12.74	200,018 USD
2021-10-15	2021-10-13	B Purchase	Chin Mark Non-Executive Director	312,500 +21.8% 16.00 5,000,000 USD	312,500 +21.8%	16.00	5,000,000 USD
2021-10-15	2021-10-13	B Purchase	Cormorant Asset Management, LP	450,000 +67.3% 16.00 7,200,000 USD	450,000 +67.3%	16.00	7,200,000 USD